Personalizing the Selection of Systemic Therapies for Moderate-to-Severe Atopic Dermatitis
Podcast 5: Reviewing Systemic Therapies for Patients with Moderate-to-Severe Atopic Dermatitis
Pre-test
Exit Survey
Questions marked with a
*
are required
100%
Contact Information
First Name
Last Name
Email Address
Treatment of moderate-to-severe AD:
Use of oral prednisone should be discouraged
Dupilumab is efficacious in those patients refractory to topicals
Systemic immunosuppressant use in pediatrics should be limited
JAK inhibitors are efficacious but have limited safety data
B and D
An 8 y/o girl with her Mom are in for a follow-up visit. Daughter can’t sleep and is having difficulty in school due to itching. She’s maintained on moisturizer and low potency TCS. Options?
Add tralokinumab
Add dupilumab
Add Abrocitinib
Switch to TCI
All of the above
B and D
Done
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close